TAP Hunter: a SVM-based system for predicting TAP ligands using local description of amino acid sequence

Volume 6 Supplement 1

Ninth International Conference on Bioinformatics (InCoB2010): Immunome Research

  • Proceedings
  • Open Access

TAP Hunter: a SVM-based system for predicting TAP ligands using local description of amino acid sequence

  • 1, 3,
  • 2,
  • 1, 3 and
  • 4, 5Email author
Immunome Research20106 (Suppl 1) :S6

https://doi.org/10.1186/1745-7580-6-S1-S6

©  Tong et al; licensee BioMed Central Ltd. 2010

  • Published:

Abstract

Background

Selective peptide transport by the transporter associated with antigen processing (TAP) represents one of the main candidate mechanisms that may regulate the presentation of antigenic peptides to HLA class I molecules. Because TAP-binding preferences may significant impact T-cell epitope selection, there is great interest in applying computational techniques to systematically discover these elements.

Results

We describe TAP Hunter, a web-based computational system for predicting TAP-binding peptides. A novel encoding scheme, based on representations of TAP peptide fragments and composition effects, allows the identification of variable-length TAP ligands using SVM as the prediction engine. The system was rigorously trained and tested using 613 experimentally verified peptide sequences. The results showed that the system has good predictive ability with area under the receiver operating characteristics curve (AROC) ≥0.88. In addition, TAP Hunter is compared against several existing public available TAP predictors and has showed either superior or comparable performance.

Conclusions

TAP Hunter provides a reliable platform for predicting variable length peptides binding onto the TAP transporter. To facilitate the usage of TAP Hunter to the scientific community, a simple, flexible and user-friendly web-server is developed and freely available at http://datam.i2r.a-star.edu.sg/taphunter/.

Keywords

  • Support Vector Machine
  • Human Leukocyte Antigen
  • Human Leukocyte Antigen Class
  • Transporter Associate With Antigen Processing
  • Presentation Pathway

Background

The binding of peptides to human leukocyte antigen (HLA) class I molecules is a prerequisite for CD8+ T cell response. Majority of these peptides are generated in the cytosol by proteosomal cleavage of endogenous proteins [1]. The degraded peptides, preferably 9-18 amino acids in length, are transported into the lumen of the endoplasmic reticulum (ER) by the transporter associated with antigen processing (TAP) for loading on HLA class I molecules [2, 3]. The ligated HLA class I complexes then leave the ER and are transported to the cell surface for presentation to T cell receptors [4]. Defects in TAP genes can severely impair peptide transport into the ER, and result in reduced surface expression of HLA class I molecules [5].

The substrate specificity of TAP has been examined in several studies. It is now known that hydrophobic aromatic residues are preferred at the C-terminus, positions (p) 3, and p7; hydrophobic or positively charged residues are preferred at p2; aromatic or acidic residues are preferred at p1; and proline is disfavored at p1 and p2 [5, 6, 7]. Different HLA class I alleles exhibit different TAP-dependencies. HLA-A2 is reportedly the least TAP-dependent; B7 can bind to other mechanisms besides TAP transport; while A3 is predominantly TAP dependent [8]. As such, improved understanding of TAP selectivity is important for elucidating its role in regulating the supply of peptides to HLA class I molecules. This is also crucial for the design of T cell-based vaccines for infectious diseases, autoimmune disorders, transplantation and cancer.

To date, a variety of computational methods have been developed to predict TAP-binding peptides. Daniel and coworkers [9] applied artificial neural networks (ANN) to simulate TAP binding experiments. Zhang et al. [10] combined ANN and hidden Markov models to predict peptide binding to human TAP. Doytchinova and colleagues [11] developed an additive QSAR model for peptides binding to TAP molecule. Bhasin and Raghava [12] utilized a cascade support vector machines (SVM)-based method to predict the binding affinities of TAP ligands, while Peters et al. [13] and Diez-Rivero et al. [14] reported the use of stabilized matrix method and SVM-based system, respectively, to predict both nonamer and variable length TAP ligands. Although numerous studies have shown the importance of sequence locality in TAP transport [12], none of the existing systems have exploited localized amino acid effect for predicting TAP binding affinity of peptides.

Here we report TAP Hunter, a web-based computational system for predicting TAP ligands using SVM as the discrimination engine. A novel data encoding scheme, based on sequence locality and composition effects, allows the system to model essential features in peptides that can bind to the TAP translocator. This simple method allows us to predict TAP ligands with an accuracy that is better than existing approaches based on full-length sequences.

Methods

Data

The dataset consists of 896 peptide sequences. In this list, to use the same dataset as those of the existing work [12, 13], we first focused on 276 TAP binding and 94 non-binding nonamer peptides, which were derived from TAP binding assays [10]. We used them for 5-fold cross validation (CV) to select the best model out of the 48 models that we examined on different amino acid positions (see Table 1 for selected models). We then trained the optimized model using all 276 binders and 94 non-binders once again, and its performance was assessed using three independent datasets: i) 91 TAP binding and 32 non-binding nonamer peptides derived from TAP binding assays [9]; and ii) 38 recently elucidated nonamer peptides from TAP dependent HLA-A1, A3, A11, A24 and B27 [15], and 12 nonamer peptides from TAP-deficient LCL721.174 cell line [16].
Table 1

Performance evaluation of SVM models using different peptide localities (selected outputs are shown)

No of a.a.

Model No.

a.a. positions used in modeling

ACC

AROC
     

5-fold CV

Independent testing

5-fold CV

Independent testing
 

1

2, 3

0.80

0.76

0.80

0.75

2

2

2, 9

0.76

0.77

0.80

0.83
 

3

3, 9

0.79

0.78

0.81

0.86
 

4

1, 2, 3

0.79

0.77

0.83

0.78

3

5

1, 2, 9

0.82

0.82

0.88

0.86
 

6

1, 3, 9

0.80

0.77

0.84

0.85
 

7

2, 3, 9

0.82

0.83

0.87

0.88
 

8

1, 2, 3, 7

0.79

0.73

0.84

0.76
 

9

1, 2, 3, 8

0.79

0.79

0.82

0.77
 

10

1, 2, 3, 9

0.84

0.82

0.88

0.88
 

11

1, 2, 7, 9

0.81

0.75

0.87

0.83

4

12

1, 2, 8, 9

0.80

0.78

0.86

0.86
 

13

1, 3, 7, 9

0.81

0.79

0.85

0.86
 

14

1, 3, 8, 9

0.82

0.81

0.83

0.86
 

15

2, 3, 7, 9

0.83

0.76

0.89

0.83
 

16

2, 3, 8, 9

0.78

0.82

0.85

0.88
 

17

1, 2, 3, 7, 8

0.79

0.76

0.84

0.74
 

18

1, 2, 3, 8, 9

0.81

0.82

0.86

0.89

5

19

1, 2, 7, 8, 9

0.82

0.76

0.87

0.83
 

20

1, 2, 3, 7, 9

0.82

0.77

0.88

0.86
 

21

1, 3, 7, 8, 9

0.80

0.80

0.85

0.83
 

22

2, 3, 7, 8, 9

0.82

0.79

0.86

0.86
 

23

1, 2, 3, 4, 5, 6

0.76

0.8

0.83

0.80

6

24

1, 2, 3, 7, 8, 9

0.82

0.79

0.85

0.86
 

25

4, 5, 6, 7, 8, 9

0.78

0.69

0.80

0.59
 

26

1, 2, 3, 4, 7, 8, 9

0.80

0.75

0.85

0.84

7

27

1, 2, 3, 5, 7, 8, 9

0.81

0.76

0.85

0.86
 

28

1, 2, 3, 6, 7, 8, 9

0.81

0.77

0.86

0.84
 

29

1, 2, 3, 5, 6, 7, 8, 9

0.81

0.82

0.86

0.85

8

30

1, 2, 3, 4, 6, 7, 8, 9

0.80

0.80

0.85

0.84
 

31

1, 2, 3, 4, 5, 7, 8, 9

0.78

0.79

0.83

0.85

9

32

1, 2, 3, 4, 5, 6, 7, 8, 9

0.79

0.78

0.84

0.83

Support vector machines

SVMs are a type of supervised statistical machine-learning techniques based on the structural risk minimization principle used for classification and regression. In this work, SVM is used to binary classify the peptides into TAP- binding or TAP non-binding. Suppose S = {(x 1 , y 1 ) … (x i , y i )} is a set of i training samples, where x is the feature vectors in d-dimensional domain (x i ∊ R d ) representing an individual peptide and y i ∊ {1,-1}. For a binary classification, the kernel function is utilized to map the input feature vectors into a higher dimensional feature space. Within this feature space, SVM modelling will locate an optimal hyperplane separating the vectors into two distinct categories. The decision function for the classifier can be written as

α i is solved by quadratic programming subjected to 0≤ α i ≤C condition, where C is the parameter to control the trade-off between the margin and training error. K represents the kernel function while sgn is the sign of the argument in the form of -1 or 1. If the function of a test instance is greater than zero, it will be tagged as positive case while a function value of less than zero is presented as negative case. This concept of kernel function mapping allows SVM to model very complex precincts and thus enable SVMs to easily handle non-linear data. Though there are many different type kernels proposed by researchers, the commonly used and broadly relevance to many applications are the linear, polynomial, radial basis functions and sigmoid kernel functions.

Model building and evaluation

TAP Hunter was implemented using the SVM-Light package [17]. The system employs the Radial Basis Function (RBF) kernel for SVM training. We also explored linear and polynomial kernel functions but they did not achieve higher performance levels (data not shown). The inputs to the SVM are binary strings or feature vectors representing encoded representations of physicochemical properties previously reported as significant for TAP binding [12]. These include hydrophobicity, aromaticity, charges and residue weight. It has been reported that the N- and C-terminal residues of TAP ligands contribute to most of the binding interactions [12]. Using the above features, truncation analysis was performed to examine the contribution of each and every peptide position to binding. 5-fold cross-validation (CV) was performed to assess the stability of the derived models. Finally, the performance of each models were assessed using sensitivity (SE), specificity (SP), accuracy (ACC) and the area under the Receiver Operating Characteristic curve (AROC) as previously described [18].

Results

System performance

The robustness of TAP Hunter using different sequence localities as inputs for training has been estimated for 5-fold CV (Table 1). The best model was achieved using descriptors derived from peptide positions N+1, N+2, N+3 and C (model 10; ACC=0.84 and AROC=0.82 for 5-fold CV; ACC=0.88 and AROC= 0.88 for Testing dataset i), consistent with existing studies that these amino acid positions are crucial for binding [12].

Comparison with existing methods

We benchmarked the performance of TAP Hunter against four existing techniques: TAPPred (SVM) [12], TAPPred (Cascade SVM) [12], Stabilized matrix method (SMM) [13] and TAPREG [14] using an independent dataset of 50 recently elucidated nonamer peptides (Testing dataset ii). Among them, only SMM and TAPREG have the capacity to predict arbitrary length ligands. Each of these techniques has its own defined threshold for discriminating TAP-binding ligands. For objective evaluation of the systems’ performance, the threshold independent AROC was adopted in this study. And to illustrate the observed AROC difference between TAP Hunter and each of the current methods is statistically significant; we used bootstrapping to randomly sample the testing dataset to into smaller sizes for statistical inference. As shown in Figure 1, the sequence locality approach as implemented in TAP Hunter consistently outperforms or is comparable to all existing techniques evaluated in this study – TAP Hunter: mean AROC=0.85 (± 0.018 95% CI); Stabilized matrix method (SMM): mean AROC=0.86 (± 0.023 95% CI); TAPPred (SVM): mean AROC=0.80 (± 0.023 95% CI); TAPPred (Cascade SVM): mean AROC=0.28 (± 0.022 95% CI); TAPREG: mean AROC=0.76 (± 0.029 95% CI). The computed p-values on the observed AROC difference between TAP Hunter and the respective methods are shown in Table 2. The results indicate that, overall, TAP Hunter is capable of screening peptides that could be transported by TAP using local description of amino acid sequence. There are also algorithms that integrate different sub-components of the antigen processing and presentation pathway such as proteasome, TAP, and HLA [19, 20]. However, we did not benchmark these systems as only the aggregate scores of prediction are provided.
Figure 1Figure 1
Figure 1

Mean AROC curve evaluation for various TAP predictors

Table 2

p-values for the observed AROC difference between TAP Hunter and each of the existing TAP predictors for nonamers ligands predictions

 

TAPPred SVM

TAPPred Cascade

SMM

TAPREG

TAP Hunter

8.2x10-4

2.2x10-16

Not Significant

5.1x10-8

Web-server implementation and description

The execution of the TAP Hunter web-server comprises of two segments, the front and the back end. The front end, written in HTML and JavaScript, consists of the web-interface designed for user input sequence(s) as well as the references and databases used for the collection of the training and evaluation datasets. The back end administration is run by several modules (written in Perl, JavaScript, HTML, CGI and Java) for (i) the input sequence(s) error assessment, (ii) the cleavage of protein sequence into the user defined peptide length, (iii) the generation sequence feature vectors, the operation of SVM-light package and (iv) output of results. TAP Hunter has been rigorously tested on Internet Explorer (IE) and Mozilla Firefox browsers and is expected to perform on other major web browsers. Typically the processing time required to perform TAP-peptide binding affinity prediction operation for 566 nonamer peptides is less than 30 seconds.

The operation of TAP Hunter is simple, flexible and user-friendly (Figure 2). TAP Hunter allows prediction for both short-length peptides and pathogen proteins to be screened for TAP binding peptides. Users either input sequence(s) in fasta format in the textbox or upload text file containing the sequence(s) to perform prediction. For short length peptide prediction, the maximum peptide length allowed is 21 amino acid residues while for protein sequence type prediction is limited to a maximum peptide length of 12 amino acid residues.
Figure 2Figure 2
Figure 2

Snapshot of the prediction process using TAP-HunterThe results are presented as a sortable table according to the selected parameters at the top.

Discussion and conclusion

The complex molecular mechanism involved in antigen processing and presentation pathway has impeded our capability to predict the adaptive nature of immune responses confidently. Discovery through experimental evaluation is expensive and time-consuming. Yet, usage of computational methods to complement laboratory experiments is likely to expedite the knowledge discovery in immunology. Particularly in recent years, we have seen increased attempts to simulate the cell-mediated immune system by integrating the proteasome, TAP, and HLA components of the antigen processing and presentation pathway [19, 20, 21, 22]. A study by Doytchinova and colleagues in 2004 has shown that TAP pre-selection could reduce the number of non-binders from 10% (TAP-independent) to 33% (TAP-dependent). In this aspect, TAP Hunter derives its feature vectors from the N- and C- terminal positions of TAP ligands that are known to exhibit binding motifs and most heavily influence the TAP binding affinity [5, 6, 7]. Our investigation has shown that this innovative solution is equally adept or even superior in discriminating nonamer TAP binding peptides than all current nonamer TAP predictors. Further refinement in the feature selection procedure may enable the development of TAP Hunter into a practical tool for pre-selecting T cell epitopes.

Declarations

Acknowledgements

This work was supported by the Science and Engineering Research Council (SERC) of A*STAR.

This article has been published as part of Immunome Research Volume 6 Supplement 1, 2010: Ninth International Conference on Bioinformatics (InCoB2010): Immunome Research. The full contents of the supplement are available online at http://www.immunome-research.com/supplements/6/S1.

Authors’ Affiliations

(1)
Laboratory of Immunogenetics and Viral Host-Pathogen Genomics, Singapore Immunology Network, 8A Biomedical Grove, #03-06, Immunos, Singapore, 138648
(2)
Bioinformatics Center, Institute for Chemical Research, Kyoto University, Gokasho Uji, 611-0011, Japan
(3)
Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, 8 Medical Drive, Singapore, 117597
(4)
Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 8 Medical Drive, Singapore, 117597
(5)
Data Mining Department, Institute for Infocomm Research, 1 Fusionopolis Way, #21-01 Connexis, South Tower, Singapore, 138632

References

  1. Ritz U, Seliger B: The transporter associated with antigen processing (TAP): structural integrity, expression, function, and its clinical relevance. Mol. Med. 2001, 7: 149-158.PubMed CentralPubMedGoogle Scholar
  2. Heemels MT, Ploegh HL: Substrate specificity of allelic variants of the TAP peptide transporter. Immunity. 1994, 1: 775-784. 10.1016/S1074-7613(94)80019-7.View ArticlePubMedGoogle Scholar
  3. van Endert PM, Tampé R, Meyer TH, Tisch R, Bach JF, McDevitt HO: A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity. 1994, 1: 491-10.1016/1074-7613(94)90091-4.View ArticlePubMedGoogle Scholar
  4. Lefranc MP, Lefranc G: The T cell receptor facts book. 2001, Academic Press. LondonGoogle Scholar
  5. Lankat-Buttgereit B, Tampé R: The transporter associated with antigen processing: function and implications in human diseases. Physiol. Rev. 2002, 82: 187-204.View ArticlePubMedGoogle Scholar
  6. van Endert PM, Riganelli D, Greco G, Fleischhauer K, Sidney J, Sette A, Bach JF: The peptide-binding motif for the human transporter associated with antigen processing. J. Exp. Med. 1995, 182: 1883-1895. 10.1084/jem.182.6.1883.View ArticlePubMedGoogle Scholar
  7. Uebel S, Kraas W, Kienle S, Wiesmüller KH, Jung G, Tampé R: Recognition principle of the TAP translocator disclosed by combinatorial peptide libraries. Proc. Natl. Acad. Sci. 1997, 94: 8976-8981. 10.1073/pnas.94.17.8976.PubMed CentralView ArticlePubMedGoogle Scholar
  8. Larsen MV, Nielsen M, Weinzier A, Lund O: TAP-independent MHC class I presentation. Curr. Immunol. Rev. 2006, 2: 233-245. 10.2174/157339506778018550.View ArticleGoogle Scholar
  9. Daniel S, Brusic V, Caillat-Zucman S, Petrovsky N, Harrison L, Riganelli D, Sinigaglia F, Gallazzi F, Hammer J, van Endert P: Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. J. Immunol. 1998, 161: 617-624.PubMedGoogle Scholar
  10. Zhang GL, Petrovsky N, Kwoh CK, August JT, Brusic V: PredTAP: a system for prediction of peptide binding to the human transporter associated with antigen processing. Immunome Res. 2006, 2: 3-10.1186/1745-7580-2-3.PubMed CentralView ArticlePubMedGoogle Scholar
  11. Doytchinova I, Hemsley S, Flower DR: Transporter associated with antigen processing preselection of peptides binding to the MHC: a bioinformatics evaluation. J. Immunol. 2004, 173: 6813-6819.View ArticlePubMedGoogle Scholar
  12. Bhasin M, Raghava GP: Analysis and prediction of affinity of TAP binding peptides using cascade SVM. Protein Sci. 2004, 13: 596-607. 10.1110/ps.03373104.PubMed CentralView ArticlePubMedGoogle Scholar
  13. Peters B, Bulik S, Tampe R, van Endert PM, Holzhütter HG: Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. J Immunol. 2003, 171: 1741-1749.View ArticlePubMedGoogle Scholar
  14. Diez-Rivero CM, Chenlo B, Zuluaga P, Reche PA: Quantitative modeling of peptide binding to TAP using support vector machine. Protein. 2009, 10: 1002-1012.Google Scholar
  15. Lata S, Bhasin M, Raghava GP: MHCBN 4.0: A database of MHC/TAP binding peptides and T-cell epitopes. BMC Research Notes. 2009, 2: 61-67. 10.1186/1756-0500-2-61.PubMed CentralView ArticlePubMedGoogle Scholar
  16. Weinzierl AO, Rudolf D, Hillen N, Tenzer S, van Endert PM, Schild H, Rammensee HG, Stevanović S: Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry. Eur. J. Immunol. 2008, 38: 1503-1510. 10.1002/eji.200838136.View ArticlePubMedGoogle Scholar
  17. Joachims T: Making large-Scale SVM learning practical. Advances in Kernel Methods - Support Vector. Edited by: Scholkopf,B. 1999, MIT-Press, Cambridge MA, 42-56.Google Scholar
  18. Muh HC, Tong JC, Tammi MT: AllerHunter: a SVM-pairwise system for assessment of allergenicity and allergic cross-reactivity in proteins. PLoS ONE. 2009, 4: e5861-10.1371/journal.pone.0005861.PubMed CentralView ArticlePubMedGoogle Scholar
  19. Doytchinova IA, Guan P, Flower DR: EpiJen: a server for multi-step T cell epitope prediction. BMC Bioinformatics. 2006, 7: 131-142. 10.1186/1471-2105-7-131.PubMed CentralView ArticlePubMedGoogle Scholar
  20. Guan P, Doytchinova IA, Zygouri C, Flower DR: MHCPred: bringing a quantitative dimension to the online prediction of MHC binding. Appl Bioinformatics. 2003, 2: 63-66.PubMedGoogle Scholar
  21. Larsen MV, Lundegaard C, Lamberth K, Buus S, Lund O, Nielsen M: Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics. 2007, 8: 424-10.1186/1471-2105-8-424.PubMed CentralView ArticlePubMedGoogle Scholar
  22. Dönnes P, Kohlbacher O: Integrated modeling of the major events in the MHC class I antigen processing pathway. Protein Sci. 2005, 14: 2132-2140. 10.1110/ps.051352405.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Tong et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Back to Immunome Research

Immunome Research archive hosted by NeuEve

Immunome Research was a scientific journal published from 2005-2010 about cutting edge immunology research, integrating genomics, and bioinformatics. NeuEve supports science, so we have put the articles originally published in Immunome Research back online.